NCT04637139View on ClinicalTrials.gov

A Study to Evaluate the Mass Balance Absorption and AME of VBR

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

December 22, 2020

Study Completion Date

December 22, 2020

Conditions
Chronic Hepatitis B
Interventions
DRUG

Vebicorvir (VBR)

300mg Vebicovir containing 2 µCi \[14C\]VBR.

Trial Locations (1)

21201

Pharmaron CPC, Baltimore

Sponsors
All Listed Sponsors
lead

Assembly Biosciences

INDUSTRY

NCT04637139 - A Study to Evaluate the Mass Balance Absorption and AME of VBR | Biotech Hunter | Biotech Hunter